TPCN2 and cancer: A comparative analysis of melanoma and HCC cell lines and tumour models revealed that the MAPK-dependent effects of TPC2 depletion (Figure 7), affecting both proliferation and immunogenicity, were specific to HCC, underscoring a tumour-type-dependent role for TPC2 in cancer progression.